Skip to Content

Delayed diagnosis of axSpA has a detrimental impact on life quality

Research shows an average delay in the diagnosis of axial spondyloarthritis (axSpA) of around 7 years – and up to 15 years in some cases – during which time the condition can progress and lead to irreversible damage. At the EULAR2021, Dr Dale Webb and colleagues call for action upon the world-wide delay in diagnosis supported by comprehensive data on stakeholder experiences and new recommendations in order to transform the landscape of axSpA care.

Delay

Lue artikkeli

Jos olet lääkäri, farmaseutti tai rajatun lääkkeenmääräämisoikeuden omaava sairaanhoitaja, pääset lukemaan artikkelin kirjautumalla käyttäjäksi BestPractice Nordic -sivustolle.

Back to top